The overlapping coinfection of hepatitis B virus and anti-hepatitis C virus antibody in tuberculosis patients: Unraveling co-infection patterns and clinical implications.
Cross-sectional analysis identifies co-infection prevalence among tuberculosis patients, highlighting the need for regular screening practices.
Key Points
Tuberculosis patients showed a hepatitis B virus prevalence of 10.57%, emphasizing co-infection rates in this group.
The study involved patient records from 2283 tuberculosis cases, with significant findings on co-infection patterns and demographics.
Cross-sectional study approach revealed higher hepatitis B and anti-hepatitis C virus testing rates in tuberculosis patients compared to the general population.
Findings suggest a strong need for integrated healthcare strategies to address the overlap of viral hepatitis and tuberculosis.